Alternative splicing of the porcine glycogen synthase kinase 3β (gsk-3β) gene with differential expression patterns and regulatory functions

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wang, Linjie ^a   Zuo, Bo ^b   Xu, Dequan ^b   Ren, Zuqing ^b   Zhang, Hongping ^a   Li, Xuewei ^a   Lei, Minggang ^b   Xiong, Yuanzhu ^b  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENOME ANALYSIS; GLYCOGEN SYNTHASE 1 GENE; GLYCOGEN SYNTHASE 2 GENE; GLYCOGEN SYNTHASE KINASE 3 BETA GENE; GLYCOGEN SYNTHASE KINASE 3 BETA1 GENE; GLYCOGEN SYNTHASE KINASE 3 BETA2 GENE; GLYCOGEN SYNTHASE KINASE 3 BETA3 GENE; GLYCOGEN SYNTHASE KINASE 3 BETA4 GENE; GLYCOGEN SYNTHASE KINASE 3 BETA5 GENE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; MALE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROTEIN ISOFORMS; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; SUS SCROFA;

SUIDAE; SUS;

EID: 84863639470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040250     Document Type: Article

References (40)

1. Woodgett JR, Cohen P, (1984) Multisite Phosphorylation of Glycogen-Synthase- Molecular-Basis for the Substrate-Specificity of Glycogen-Synthase Kinase-3 and Casein Kinase-Ii (Glycogen-Synthase Kinase-5). Biochimica Et Biophysica Acta 788: 339-347.
2. Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, et al. (1980) Glycogen-Synthase from Rabbit Skeletal-Muscle- Amino-Acid-Sequence at the Sites Phosphorylated by Glycogen-Synthase Kinase-3, and Extension of the N-Terminal Sequence Containing the Site Phosphorylated by Phosphorylase-Kinase. Euro J Biochem 107: 529-537.
3. Woodgett JR, (1990) Molecular-Cloning and Expression of Glycogen-Synthase Kinase-3 Factor-A. EMBO J 9: 2431-2438.
4. Ding VW, Chen RH, McCormick F, (2000) Differential regulation of glycogen synthase kinase 3 beta by insulin and Wnt signaling. J Biol Chem 275: 32475-32481.
5. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, et al. (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272: 1023-1026.
6. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R, (1997) β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
7. Hecht A, Kemler R, (2000) Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep 1: 24-28.
8. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA, (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
9. Cross DA, Watt PW, Shaw M, van der Kaay J, Downes CP, et al. (1997) Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 406: 211-215.
10. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
11. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST, (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21: 281-293.
12. Mukai F, Ishiguro K, Sano Y, Fujita SC, (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J Neurochem 81: 1073-1083.
13. Schaffer B, Wiedau-Pazos M, Geschwind DH, (2003) Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302: 73-81.
14. Saeki K, Machida M, Kinoshita Y, Takasawa R, Tanuma SI, (2011) Glycogen Synthase Kinase-3 beta 2 Has Lower Phosphorylation Activity to Tau than Glycogen Synthase Kinase-3 beta 1. Biol Pharm Bull 34: 146-149.
15. Soutar MPM, Kim WY, Williamson R, Peggie M, Hastie CJ, et al. (2010) Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain. J Neurochem 115: 974-983.
16. Castano Z, Gordon-Weeks PR, Kypta RM, (2010) The neuron-specific isoform of glycogen synthase kinase-3 beta is required for axon growth. J Neurochem 113: 117-130.
17. Wood-Kaczmar A, Kraus M, Ishiguro K, Philpott KL, Gordon-Weeks PR, (2009) An alternatively spliced form of glycogen synthase kinase-3 beta is targeted to growing neurites and growth cones. Mol Cell Neurosci 42: 184-194.
18. Maccioni RB, Munoz JP, Barbeito L, (2001) The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32: 367-381.
19. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, et al. (2000) Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49: 263-271.
20. Frame S, Cohen P, (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochemical J 359: 1-16.
21. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, et al. (2001) The structure of phosphorylated GSK-3 beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9: 1143-1152.
22. Dajani R, Fraser E, Roe SM, Young N, Good V, et al. (2001) Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105: 721-732.
23. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, et al. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A 97: 11960-11965.
24. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR, (1993) Modulation of the Glycogen-Synthase Kinase-3 Family by Tyrosine Phosphorylation. EMBO J 12: 803-808.
25. Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, et al. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320: 667-670.
26. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, et al. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013.
27. Ciaraldi TP, Carter L, Mudaliar S, Henry RR, (2010) GSK-3 beta and control of glucose metabolism and insulin action in human skeletal muscle. Mol Cell Endocrinol 315: 153-158.
28. Wang L, Xiong Y, Zuo B, Lei M, Ren Z, et al. (2012) Molecular and functional characterization of glycogen synthase in the porcine satellite cells under insulin treatment. Mol Cell Biochem 360: 169-180.
29. Tullai JW, Chen J, Schaffer ME, Kamenetsky E, Kasif S, et al. (2007) Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells (vol 282, pg 9482, 2007). J Biol Chem 282: 14684-14684.
30. Graham JR, Tullai JW, Cooper GM, (2010) GSK-3 Represses Growth Factor-inducible Genes by Inhibiting NF-kappa B in Quiescent Cells. Journal of Biological Chemistry 285: 4472-4480.
31. Tullai JW, Tacheva S, Owens LJ, Graham JR, Cooper GM, (2011) AP-1 Is a Component of the Transcriptional Network Regulated by GSK-3 in Quiescent Cells. PLoS ONE 6: e20150.
32. Goetschel F, Kern C, Lang S, Sparna T, Markmann C, et al. (2008) Inhibition of GSK3 differentially modulates NF-kappa B, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis. Exp Cell Res 314: 1351-1366.
33. Liang MH, Chuang DM, (2006) Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. Journal of Biological Chemistry 281: 30479-30484.
34. MacAulay K, Blair AS, Hajduch E, Terashima T, Baba O, et al. (2005) Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J Biol Chem 280: 9509-9518.
35. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, et al. (1999) The role of glycogen synthase kinase 3 beta in insulin-stimulated glucose metabolism. J Biol Chem 274: 17934-17940.
36. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA, (1995) Inhibition of Glycogen-Synthase Kinase-3 by Insulin-Mediated by Protein-Kinase-B. Nature 378: 785-789.
37. Meares GP, Jope RS, (2007) Resolution of the nuclear localization mechanism of glycogen synthase kinase-3- Functional effects in apoptosis. J Biol Chem 282: 16989-17001.
38. Bijur GN, Jope RS, (2001) Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem 276: 37436-37442.
39. Franca-Koh J, Yeo M, Fraser E, Young N, Dale TC, (2002) The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. J Biol Chem 277: 43844-43848.
40. Fraser E, Young N, Dajani R, Franca-Koh J, Ryves J, et al. (2002) Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J Biol Chem 277: 2176-2185.